291 related articles for article (PubMed ID: 36995469)
41. IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?
Atzeni F; Siragusano C; Masala IF; Antonio C; Valentina P; D'Angelo S
Expert Opin Biol Ther; 2022 Jul; 22(7):843-853. PubMed ID: 35722768
[TBL] [Abstract][Full Text] [Related]
42. Evaluating Inflammatory Versus Mechanical Back Pain in Individuals with Psoriatic Arthritis: A Review of the Literature.
Grinnell-Merrick LL; Lydon EJ; Mixon AM; Saalfeld W
Rheumatol Ther; 2020 Dec; 7(4):667-684. PubMed ID: 32935330
[TBL] [Abstract][Full Text] [Related]
43. Axial Spondyloarthritis in Japan.
Kameda H; Kishimoto M; Kobayashi S; Tomita T; Morita A; Yamamura M
Curr Rheumatol Rep; 2022 May; 24(5):149-155. PubMed ID: 35380380
[TBL] [Abstract][Full Text] [Related]
44. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?
Chandran V
Curr Opin Rheumatol; 2019 Jul; 31(4):329-334. PubMed ID: 31135567
[TBL] [Abstract][Full Text] [Related]
45. Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies.
McGonagle D; McInnes IB; Deodhar A; Schett G; Shawi M; Kafka S; Karyekar CS; Kollmeier AP; Hsia EC; Xu XL; Sheng S; Agarwal P; Zhou B; Ritchlin CT; Rahman P; Mease PJ
Rheumatology (Oxford); 2021 Nov; 60(11):5337-5350. PubMed ID: 33822898
[TBL] [Abstract][Full Text] [Related]
46. Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
Kaplan H; Cengiz G; Şaş S; Eldemir YÖ
Clin Rheumatol; 2023 Nov; 42(11):2959-2969. PubMed ID: 37470884
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of a special concept of physical therapy in spondyloarthritis: German multimodal rheumatologic complex treatment for spondyloarthritis.
Klemm P; Hudowenz O; Asendorf T; Dischereit G; Müller-Ladner U; Lange U; Tarner IH
Clin Rheumatol; 2020 May; 39(5):1513-1520. PubMed ID: 31916106
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Clinical Diagnosis of Axial Psoriatic Arthritis (PsA) or Elevated Patient-reported Spine Pain in CorEvitas' PsA/Spondyloarthritis Registry.
Ogdie A; Blachley T; Lakin PR; Dube B; McLean RR; Hur P; Mease PJ
J Rheumatol; 2022 Mar; 49(3):281-290. PubMed ID: 34853090
[TBL] [Abstract][Full Text] [Related]
49. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Feld J; Ye JY; Chandran V; Inman RD; Haroon N; Cook R; Gladman DD
Rheumatology (Oxford); 2020 Jun; 59(6):1340-1346. PubMed ID: 31593590
[TBL] [Abstract][Full Text] [Related]
50. Axial Psoriatic Arthritis.
Gladman DD
Curr Rheumatol Rep; 2021 Apr; 23(6):35. PubMed ID: 33909178
[TBL] [Abstract][Full Text] [Related]
51. The role of IL-23 and the use of IL-23 inhibitors in psoriatic arthritis.
Fragoulis GE; Siebert S
Musculoskeletal Care; 2022 Nov; 20 Suppl 1(Suppl 1):S12-S21. PubMed ID: 36069174
[TBL] [Abstract][Full Text] [Related]
52. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis.
Yap KS; Ye JY; Li S; Gladman DD; Chandran V
Ann Rheum Dis; 2018 Nov; 77(11):1573-1577. PubMed ID: 30077991
[TBL] [Abstract][Full Text] [Related]
53. Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study.
Proft F; Lüders S; Hunter T; Luna G; Rios Rodriguez V; Protopopov M; Meier K; Kokolakis G; Ghoreschi K; Poddubnyy D
Ann Rheum Dis; 2022 Aug; 81(11):1534-40. PubMed ID: 35922123
[TBL] [Abstract][Full Text] [Related]
54. Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.
Rubbert-Roth A; Kakehasi AM; Takeuchi T; Schmalzing M; Palac H; Coombs D; Liu J; Anyanwu SI; Lippe R; Curtis JR
Rheumatol Ther; 2024 Feb; 11(1):97-112. PubMed ID: 37982966
[TBL] [Abstract][Full Text] [Related]
55. Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis.
McInnes IB; Rahman P; Gottlieb AB; Hsia EC; Kollmeier AP; Xu XL; Jiang Y; Sheng S; Shawi M; Chakravarty SD; van der Heijde D; Mease PJ
Arthritis Rheumatol; 2022 Mar; 74(3):475-485. PubMed ID: 34719872
[TBL] [Abstract][Full Text] [Related]
56. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life.
Aydin SZ; Kucuksahin O; Kilic L; Dogru A; Bayindir O; Ozisler C; Omma A; Tarhan EF; Erden A; Kimyon G; Can M; Dalkilic E; Yavuz S; Ureyen SB; Gunal EK; Alhussain FA; Akyol L; Balkarli A; Yilmaz S; Cinar M; Aydin MT; Solmaz D; Mercan R; Erten S; Kalyoncu U
Clin Rheumatol; 2018 Dec; 37(12):3443-3448. PubMed ID: 29948352
[TBL] [Abstract][Full Text] [Related]
57. Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies.
Aureal M; Seauve M; Laplane S; Lega JC; Cabrera N; Coury F
RMD Open; 2023 Sep; 9(3):. PubMed ID: 37714666
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).
Kavanaugh A; Puig L; Gottlieb AB; Ritchlin C; You Y; Li S; Song M; Randazzo B; Rahman P; McInnes IB
Ann Rheum Dis; 2016 Nov; 75(11):1984-1988. PubMed ID: 27098404
[TBL] [Abstract][Full Text] [Related]
59. Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes.
Hammitzsch A; Ossadnik A; Bachmann Q; Merwald-Fraenk H; Lorenz G; Witt M; Wiesent F; Mühlhofer H; Simone D; Bowness P; Heemann U; Arbogast M; Moog P; Schmaderer C
Front Immunol; 2024; 15():1355824. PubMed ID: 38799447
[TBL] [Abstract][Full Text] [Related]
60. Clinical characteristics of axial spondyloarthritis patients in China: results from ChinaSpA, the Chinese Spondyloarthritis Registry.
Su J; Wang R; Duan X; Wang Y; Wu Z; Yang M; Xu J; Fan W; Zhao C; Li Q; Wang X; Zhu J; Wu L; Li M; Zeng X
Clin Exp Rheumatol; 2022 Mar; 40(3):544-550. PubMed ID: 33938794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
